Dermatological Therapeutics Market
1 Study Coverage
1.1 Dermatological Therapeutics Product Introduction
1.2 Market by Type
1.2.1 Global Dermatological Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Anti-infectives
1.2.3 Corticosteroids
1.2.4 Anti Psoriasis
1.2.5 Anti-acne
1.2.6 Others
1.3 Market by Application
1.3.1 Global Dermatological Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Dermatological Therapeutics Sales Estimates and Forecasts 2017-2028
2.2 Global Dermatological Therapeutics Revenue Estimates and Forecasts 2017-2028
2.3 Global Dermatological Therapeutics Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Dermatological Therapeutics Sales by Region
2.4.1 Global Dermatological Therapeutics Sales by Region (2017-2022)
2.4.2 Global Sales Dermatological Therapeutics by Region (2023-2028)
2.5 Global Dermatological Therapeutics Revenue by Region
2.5.1 Global Dermatological Therapeutics Revenue by Region (2017-2022)
2.5.2 Global Dermatological Therapeutics Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Dermatological Therapeutics Sales by Manufacturers
3.1.1 Global Top Dermatological Therapeutics Manufacturers by Sales (2017-2022)
3.1.2 Global Dermatological Therapeutics Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Dermatological Therapeutics in 2021
3.2 Global Dermatological Therapeutics Revenue by Manufacturers
3.2.1 Global Dermatological Therapeutics Revenue by Manufacturers (2017-2022)
3.2.2 Global Dermatological Therapeutics Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Dermatological Therapeutics Revenue in 2021
3.3 Global Dermatological Therapeutics Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Dermatological Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Dermatological Therapeutics Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Dermatological Therapeutics Sales by Type
4.1.1 Global Dermatological Therapeutics Historical Sales by Type (2017-2022)
4.1.2 Global Dermatological Therapeutics Forecasted Sales by Type (2023-2028)
4.1.3 Global Dermatological Therapeutics Sales Market Share by Type (2017-2028)
4.2 Global Dermatological Therapeutics Revenue by Type
4.2.1 Global Dermatological Therapeutics Historical Revenue by Type (2017-2022)
4.2.2 Global Dermatological Therapeutics Forecasted Revenue by Type (2023-2028)
4.2.3 Global Dermatological Therapeutics Revenue Market Share by Type (2017-2028)
4.3 Global Dermatological Therapeutics Price by Type
4.3.1 Global Dermatological Therapeutics Price by Type (2017-2022)
4.3.2 Global Dermatological Therapeutics Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Dermatological Therapeutics Sales by Application
5.1.1 Global Dermatological Therapeutics Historical Sales by Application (2017-2022)
5.1.2 Global Dermatological Therapeutics Forecasted Sales by Application (2023-2028)
5.1.3 Global Dermatological Therapeutics Sales Market Share by Application (2017-2028)
5.2 Global Dermatological Therapeutics Revenue by Application
5.2.1 Global Dermatological Therapeutics Historical Revenue by Application (2017-2022)
5.2.2 Global Dermatological Therapeutics Forecasted Revenue by Application (2023-2028)
5.2.3 Global Dermatological Therapeutics Revenue Market Share by Application (2017-2028)
5.3 Global Dermatological Therapeutics Price by Application
5.3.1 Global Dermatological Therapeutics Price by Application (2017-2022)
5.3.2 Global Dermatological Therapeutics Price Forecast by Application (2023-2028)
6 North America
6.1 North America Dermatological Therapeutics Market Size by Type
6.1.1 North America Dermatological Therapeutics Sales by Type (2017-2028)
6.1.2 North America Dermatological Therapeutics Revenue by Type (2017-2028)
6.2 North America Dermatological Therapeutics Market Size by Application
6.2.1 North America Dermatological Therapeutics Sales by Application (2017-2028)
6.2.2 North America Dermatological Therapeutics Revenue by Application (2017-2028)
6.3 North America Dermatological Therapeutics Market Size by Country
6.3.1 North America Dermatological Therapeutics Sales by Country (2017-2028)
6.3.2 North America Dermatological Therapeutics Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Dermatological Therapeutics Market Size by Type
7.1.1 Europe Dermatological Therapeutics Sales by Type (2017-2028)
7.1.2 Europe Dermatological Therapeutics Revenue by Type (2017-2028)
7.2 Europe Dermatological Therapeutics Market Size by Application
7.2.1 Europe Dermatological Therapeutics Sales by Application (2017-2028)
7.2.2 Europe Dermatological Therapeutics Revenue by Application (2017-2028)
7.3 Europe Dermatological Therapeutics Market Size by Country
7.3.1 Europe Dermatological Therapeutics Sales by Country (2017-2028)
7.3.2 Europe Dermatological Therapeutics Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Dermatological Therapeutics Market Size by Type
8.1.1 Asia Pacific Dermatological Therapeutics Sales by Type (2017-2028)
8.1.2 Asia Pacific Dermatological Therapeutics Revenue by Type (2017-2028)
8.2 Asia Pacific Dermatological Therapeutics Market Size by Application
8.2.1 Asia Pacific Dermatological Therapeutics Sales by Application (2017-2028)
8.2.2 Asia Pacific Dermatological Therapeutics Revenue by Application (2017-2028)
8.3 Asia Pacific Dermatological Therapeutics Market Size by Region
8.3.1 Asia Pacific Dermatological Therapeutics Sales by Region (2017-2028)
8.3.2 Asia Pacific Dermatological Therapeutics Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Dermatological Therapeutics Market Size by Type
9.1.1 Latin America Dermatological Therapeutics Sales by Type (2017-2028)
9.1.2 Latin America Dermatological Therapeutics Revenue by Type (2017-2028)
9.2 Latin America Dermatological Therapeutics Market Size by Application
9.2.1 Latin America Dermatological Therapeutics Sales by Application (2017-2028)
9.2.2 Latin America Dermatological Therapeutics Revenue by Application (2017-2028)
9.3 Latin America Dermatological Therapeutics Market Size by Country
9.3.1 Latin America Dermatological Therapeutics Sales by Country (2017-2028)
9.3.2 Latin America Dermatological Therapeutics Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Dermatological Therapeutics Market Size by Type
10.1.1 Middle East and Africa Dermatological Therapeutics Sales by Type (2017-2028)
10.1.2 Middle East and Africa Dermatological Therapeutics Revenue by Type (2017-2028)
10.2 Middle East and Africa Dermatological Therapeutics Market Size by Application
10.2.1 Middle East and Africa Dermatological Therapeutics Sales by Application (2017-2028)
10.2.2 Middle East and Africa Dermatological Therapeutics Revenue by Application (2017-2028)
10.3 Middle East and Africa Dermatological Therapeutics Market Size by Country
10.3.1 Middle East and Africa Dermatological Therapeutics Sales by Country (2017-2028)
10.3.2 Middle East and Africa Dermatological Therapeutics Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 AGI Dermatics
11.1.1 AGI Dermatics Corporation Information
11.1.2 AGI Dermatics Overview
11.1.3 AGI Dermatics Dermatological Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 AGI Dermatics Dermatological Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AGI Dermatics Recent Developments
11.2 Allergan
11.2.1 Allergan Corporation Information
11.2.2 Allergan Overview
11.2.3 Allergan Dermatological Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Allergan Dermatological Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Allergan Recent Developments
11.3 Amgen
11.3.1 Amgen Corporation Information
11.3.2 Amgen Overview
11.3.3 Amgen Dermatological Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Amgen Dermatological Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Amgen Recent Developments
11.4 Chester Valley
11.4.1 Chester Valley Corporation Information
11.4.2 Chester Valley Overview
11.4.3 Chester Valley Dermatological Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Chester Valley Dermatological Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Chester Valley Recent Developments
11.5 Dermik
11.5.1 Dermik Corporation Information
11.5.2 Dermik Overview
11.5.3 Dermik Dermatological Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Dermik Dermatological Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Dermik Recent Developments
11.6 Eisai
11.6.1 Eisai Corporation Information
11.6.2 Eisai Overview
11.6.3 Eisai Dermatological Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Eisai Dermatological Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Eisai Recent Developments
11.7 Ferndale
11.7.1 Ferndale Corporation Information
11.7.2 Ferndale Overview
11.7.3 Ferndale Dermatological Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Ferndale Dermatological Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Ferndale Recent Developments
11.8 Genentech
11.8.1 Genentech Corporation Information
11.8.2 Genentech Overview
11.8.3 Genentech Dermatological Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Genentech Dermatological Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Genentech Recent Developments
11.9 Medicis
11.9.1 Medicis Corporation Information
11.9.2 Medicis Overview
11.9.3 Medicis Dermatological Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Medicis Dermatological Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Medicis Recent Developments
11.10 Onset Therapeutics
11.10.1 Onset Therapeutics Corporation Information
11.10.2 Onset Therapeutics Overview
11.10.3 Onset Therapeutics Dermatological Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Onset Therapeutics Dermatological Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Onset Therapeutics Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Dermatological Therapeutics Industry Chain Analysis
12.2 Dermatological Therapeutics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Dermatological Therapeutics Production Mode & Process
12.4 Dermatological Therapeutics Sales and Marketing
12.4.1 Dermatological Therapeutics Sales Channels
12.4.2 Dermatological Therapeutics Distributors
12.5 Dermatological Therapeutics Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Dermatological Therapeutics Industry Trends
13.2 Dermatological Therapeutics Market Drivers
13.3 Dermatological Therapeutics Market Challenges
13.4 Dermatological Therapeutics Market Restraints
14 Key Findings in The Global Dermatological Therapeutics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Dermatological Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Anti-infectives
Table 3. Major Manufacturers of Corticosteroids
Table 4. Major Manufacturers of Anti Psoriasis
Table 5. Major Manufacturers of Anti-acne
Table 6. Major Manufacturers of Others
Table 7. Global Dermatological Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Dermatological Therapeutics Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Dermatological Therapeutics Sales by Region (2017-2022) & (K Units)
Table 10. Global Dermatological Therapeutics Sales Market Share by Region (2017-2022)
Table 11. Global Dermatological Therapeutics Sales by Region (2023-2028) & (K Units)
Table 12. Global Dermatological Therapeutics Sales Market Share by Region (2023-2028)
Table 13. Global Dermatological Therapeutics Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Dermatological Therapeutics Revenue Market Share by Region (2017-2022)
Table 15. Global Dermatological Therapeutics Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Dermatological Therapeutics Revenue Market Share by Region (2023-2028)
Table 17. Global Dermatological Therapeutics Sales by Manufacturers (2017-2022) & (K Units)
Table 18. Global Dermatological Therapeutics Sales Share by Manufacturers (2017-2022)
Table 19. Global Dermatological Therapeutics Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Dermatological Therapeutics Revenue Share by Manufacturers (2017-2022)
Table 21. Dermatological Therapeutics Price by Manufacturers (2017-2022) &(US$/Unit)
Table 22. Global Dermatological Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Dermatological Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatological Therapeutics as of 2021)
Table 24. Dermatological Therapeutics Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Dermatological Therapeutics Product Offered
Table 26. Date of Manufacturers Enter into Dermatological Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Dermatological Therapeutics Sales by Type (2017-2022) & (K Units)
Table 29. Global Dermatological Therapeutics Sales by Type (2023-2028) & (K Units)
Table 30. Global Dermatological Therapeutics Sales Share by Type (2017-2022)
Table 31. Global Dermatological Therapeutics Sales Share by Type (2023-2028)
Table 32. Global Dermatological Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Dermatological Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Dermatological Therapeutics Revenue Share by Type (2017-2022)
Table 35. Global Dermatological Therapeutics Revenue Share by Type (2023-2028)
Table 36. Dermatological Therapeutics Price by Type (2017-2022) & (US$/Unit)
Table 37. Global Dermatological Therapeutics Price Forecast by Type (2023-2028) & (US$/Unit)
Table 38. Global Dermatological Therapeutics Sales by Application (2017-2022) & (K Units)
Table 39. Global Dermatological Therapeutics Sales by Application (2023-2028) & (K Units)
Table 40. Global Dermatological Therapeutics Sales Share by Application (2017-2022)
Table 41. Global Dermatological Therapeutics Sales Share by Application (2023-2028)
Table 42. Global Dermatological Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Dermatological Therapeutics Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Dermatological Therapeutics Revenue Share by Application (2017-2022)
Table 45. Global Dermatological Therapeutics Revenue Share by Application (2023-2028)
Table 46. Dermatological Therapeutics Price by Application (2017-2022) & (US$/Unit)
Table 47. Global Dermatological Therapeutics Price Forecast by Application (2023-2028) & (US$/Unit)
Table 48. North America Dermatological Therapeutics Sales by Type (2017-2022) & (K Units)
Table 49. North America Dermatological Therapeutics Sales by Type (2023-2028) & (K Units)
Table 50. North America Dermatological Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Dermatological Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Dermatological Therapeutics Sales by Application (2017-2022) & (K Units)
Table 53. North America Dermatological Therapeutics Sales by Application (2023-2028) & (K Units)
Table 54. North America Dermatological Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Dermatological Therapeutics Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Dermatological Therapeutics Sales by Country (2017-2022) & (K Units)
Table 57. North America Dermatological Therapeutics Sales by Country (2023-2028) & (K Units)
Table 58. North America Dermatological Therapeutics Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Dermatological Therapeutics Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Dermatological Therapeutics Sales by Type (2017-2022) & (K Units)
Table 61. Europe Dermatological Therapeutics Sales by Type (2023-2028) & (K Units)
Table 62. Europe Dermatological Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Dermatological Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Dermatological Therapeutics Sales by Application (2017-2022) & (K Units)
Table 65. Europe Dermatological Therapeutics Sales by Application (2023-2028) & (K Units)
Table 66. Europe Dermatological Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Dermatological Therapeutics Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Dermatological Therapeutics Sales by Country (2017-2022) & (K Units)
Table 69. Europe Dermatological Therapeutics Sales by Country (2023-2028) & (K Units)
Table 70. Europe Dermatological Therapeutics Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Dermatological Therapeutics Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Dermatological Therapeutics Sales by Type (2017-2022) & (K Units)
Table 73. Asia Pacific Dermatological Therapeutics Sales by Type (2023-2028) & (K Units)
Table 74. Asia Pacific Dermatological Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Dermatological Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Dermatological Therapeutics Sales by Application (2017-2022) & (K Units)
Table 77. Asia Pacific Dermatological Therapeutics Sales by Application (2023-2028) & (K Units)
Table 78. Asia Pacific Dermatological Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Dermatological Therapeutics Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Dermatological Therapeutics Sales by Region (2017-2022) & (K Units)
Table 81. Asia Pacific Dermatological Therapeutics Sales by Region (2023-2028) & (K Units)
Table 82. Asia Pacific Dermatological Therapeutics Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Dermatological Therapeutics Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Dermatological Therapeutics Sales by Type (2017-2022) & (K Units)
Table 85. Latin America Dermatological Therapeutics Sales by Type (2023-2028) & (K Units)
Table 86. Latin America Dermatological Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Dermatological Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Dermatological Therapeutics Sales by Application (2017-2022) & (K Units)
Table 89. Latin America Dermatological Therapeutics Sales by Application (2023-2028) & (K Units)
Table 90. Latin America Dermatological Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Dermatological Therapeutics Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Dermatological Therapeutics Sales by Country (2017-2022) & (K Units)
Table 93. Latin America Dermatological Therapeutics Sales by Country (2023-2028) & (K Units)
Table 94. Latin America Dermatological Therapeutics Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Dermatological Therapeutics Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Dermatological Therapeutics Sales by Type (2017-2022) & (K Units)
Table 97. Middle East and Africa Dermatological Therapeutics Sales by Type (2023-2028) & (K Units)
Table 98. Middle East and Africa Dermatological Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Dermatological Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Dermatological Therapeutics Sales by Application (2017-2022) & (K Units)
Table 101. Middle East and Africa Dermatological Therapeutics Sales by Application (2023-2028) & (K Units)
Table 102. Middle East and Africa Dermatological Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Dermatological Therapeutics Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Dermatological Therapeutics Sales by Country (2017-2022) & (K Units)
Table 105. Middle East and Africa Dermatological Therapeutics Sales by Country (2023-2028) & (K Units)
Table 106. Middle East and Africa Dermatological Therapeutics Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Dermatological Therapeutics Revenue by Country (2023-2028) & (US$ Million)
Table 108. AGI Dermatics Corporation Information
Table 109. AGI Dermatics Description and Major Businesses
Table 110. AGI Dermatics Dermatological Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 111. AGI Dermatics Dermatological Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. AGI Dermatics Recent Developments
Table 113. Allergan Corporation Information
Table 114. Allergan Description and Major Businesses
Table 115. Allergan Dermatological Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 116. Allergan Dermatological Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Allergan Recent Developments
Table 118. Amgen Corporation Information
Table 119. Amgen Description and Major Businesses
Table 120. Amgen Dermatological Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 121. Amgen Dermatological Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Amgen Recent Developments
Table 123. Chester Valley Corporation Information
Table 124. Chester Valley Description and Major Businesses
Table 125. Chester Valley Dermatological Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 126. Chester Valley Dermatological Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Chester Valley Recent Developments
Table 128. Dermik Corporation Information
Table 129. Dermik Description and Major Businesses
Table 130. Dermik Dermatological Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 131. Dermik Dermatological Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Dermik Recent Developments
Table 133. Eisai Corporation Information
Table 134. Eisai Description and Major Businesses
Table 135. Eisai Dermatological Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 136. Eisai Dermatological Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Eisai Recent Developments
Table 138. Ferndale Corporation Information
Table 139. Ferndale Description and Major Businesses
Table 140. Ferndale Dermatological Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 141. Ferndale Dermatological Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Ferndale Recent Developments
Table 143. Genentech Corporation Information
Table 144. Genentech Description and Major Businesses
Table 145. Genentech Dermatological Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 146. Genentech Dermatological Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Genentech Recent Developments
Table 148. Medicis Corporation Information
Table 149. Medicis Description and Major Businesses
Table 150. Medicis Dermatological Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 151. Medicis Dermatological Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Medicis Recent Developments
Table 153. Onset Therapeutics Corporation Information
Table 154. Onset Therapeutics Description and Major Businesses
Table 155. Onset Therapeutics Dermatological Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 156. Onset Therapeutics Dermatological Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Onset Therapeutics Recent Developments
Table 158. Key Raw Materials Lists
Table 159. Raw Materials Key Suppliers Lists
Table 160. Dermatological Therapeutics Distributors List
Table 161. Dermatological Therapeutics Customers List
Table 162. Dermatological Therapeutics Market Trends
Table 163. Dermatological Therapeutics Market Drivers
Table 164. Dermatological Therapeutics Market Challenges
Table 165. Dermatological Therapeutics Market Restraints
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Dermatological Therapeutics Product Picture
Figure 3. Global Dermatological Therapeutics Market Share by Type in 2021 & 2028
Figure 3. Anti-infectives Product Picture
Figure 4. Corticosteroids Product Picture
Figure 5. Anti Psoriasis Product Picture
Figure 6. Anti-acne Product Picture
Figure 7. Others Product Picture
Figure 8. Global Dermatological Therapeutics Market Share by Application in 2021 & 2028
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Dermatological Therapeutics Report Years Considered
Figure 12. Global Dermatological Therapeutics Sales 2017-2028 (K Units)
Figure 13. Global Dermatological Therapeutics Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Dermatological Therapeutics Revenue 2017-2028 (US$ Million)
Figure 15. Global Dermatological Therapeutics Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Dermatological Therapeutics Sales Market Share by Region (2017-2022)
Figure 17. Global Dermatological Therapeutics Sales Market Share by Region (2023-2028)
Figure 18. North America Dermatological Therapeutics Sales YoY (2017-2028) & (K Units)
Figure 19. North America Dermatological Therapeutics Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Dermatological Therapeutics Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Dermatological Therapeutics Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Dermatological Therapeutics Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Dermatological Therapeutics Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Dermatological Therapeutics Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Dermatological Therapeutics Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Dermatological Therapeutics Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Dermatological Therapeutics Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Dermatological Therapeutics Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Dermatological Therapeutics in the World: Market Share by Dermatological Therapeutics Revenue in 2021
Figure 30. Global Dermatological Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Dermatological Therapeutics Sales Market Share by Type (2017-2028)
Figure 32. Global Dermatological Therapeutics Revenue Market Share by Type (2017-2028)
Figure 33. Global Dermatological Therapeutics Sales Market Share by Application (2017-2028)
Figure 34. Global Dermatological Therapeutics Revenue Market Share by Application (2017-2028)
Figure 35. North America Dermatological Therapeutics Sales Market Share by Type (2017-2028)
Figure 36. North America Dermatological Therapeutics Revenue Market Share by Type (2017-2028)
Figure 37. North America Dermatological Therapeutics Sales Market Share by Application (2017-2028)
Figure 38. North America Dermatological Therapeutics Revenue Market Share by Application (2017-2028)
Figure 39. North America Dermatological Therapeutics Sales Share by Country (2017-2028)
Figure 40. North America Dermatological Therapeutics Revenue Share by Country (2017-2028)
Figure 41. U.S. Dermatological Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Dermatological Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Dermatological Therapeutics Sales Market Share by Type (2017-2028)
Figure 44. Europe Dermatological Therapeutics Revenue Market Share by Type (2017-2028)
Figure 45. Europe Dermatological Therapeutics Sales Market Share by Application (2017-2028)
Figure 46. Europe Dermatological Therapeutics Revenue Market Share by Application (2017-2028)
Figure 47. Europe Dermatological Therapeutics Sales Share by Country (2017-2028)
Figure 48. Europe Dermatological Therapeutics Revenue Share by Country (2017-2028)
Figure 49. Germany Dermatological Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 50. France Dermatological Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Dermatological Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Dermatological Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Dermatological Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Dermatological Therapeutics Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Dermatological Therapeutics Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Dermatological Therapeutics Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Dermatological Therapeutics Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Dermatological Therapeutics Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Dermatological Therapeutics Revenue Share by Region (2017-2028)
Figure 60. China Dermatological Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Dermatological Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Dermatological Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 63. India Dermatological Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Dermatological Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 65. Taiwan Dermatological Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Dermatological Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Dermatological Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Dermatological Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 69. Philippines Dermatological Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Dermatological Therapeutics Sales Market Share by Type (2017-2028)
Figure 71. Latin America Dermatological Therapeutics Revenue Market Share by Type (2017-2028)
Figure 72. Latin America Dermatological Therapeutics Sales Market Share by Application (2017-2028)
Figure 73. Latin America Dermatological Therapeutics Revenue Market Share by Application (2017-2028)
Figure 74. Latin America Dermatological Therapeutics Sales Share by Country (2017-2028)
Figure 75. Latin America Dermatological Therapeutics Revenue Share by Country (2017-2028)
Figure 76. Mexico Dermatological Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil Dermatological Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina Dermatological Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa Dermatological Therapeutics Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Dermatological Therapeutics Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Dermatological Therapeutics Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Dermatological Therapeutics Revenue Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Dermatological Therapeutics Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa Dermatological Therapeutics Revenue Share by Country (2017-2028)
Figure 85. Turkey Dermatological Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia Dermatological Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 87. UAE Dermatological Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 88. Dermatological Therapeutics Value Chain
Figure 89. Dermatological Therapeutics Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed